No black box warning on record for Diltiazem Hcl Er

As of the latest FDA labeling reviewed, Diltiazem Hcl Er (DILTIAZEM HCL ER) does not carry a black box warning. Standard warnings and precautions still apply — see the full Diltiazem Hcl Er medicine page for the complete safety profile.

Other warnings & precautions

Cardiac Conduction: Diltiazem hydrochloride prolongs AV node refractory periods without significantly prolonging sinus node recovery time, except in patients with sick sinus syndrome. This effect may rarely result in abnormally slow heart rates (particularly in patients with sick sinus syndrome) or second- or third-degree AV block (13 of 3290 patients or 0.40%). Concomitant use of diltiazem with b

No black box warning on record for Diltiazem Hcl Er

Other warnings & precautions

Cardiac Conduction: Diltiazem hydrochloride prolongs AV node refractory periods without significantly prolonging sinus node recovery time, except in patients with sick sinus syndrome. This effect may rarely result in abnormally slow heart rates (particularly in patients with sick sinus syndrome) or second- or third-degree AV block (13 of 3290 patients or 0.40%). Concomitant use of diltiazem with b

Diltiazem Hcl Er Black Box Warning

No black box warning on record for Diltiazem Hcl Er

Other warnings & precautions

Diltiazem Hcl Er Black Box Warning

No black box warning on record for Diltiazem Hcl Er

Other warnings & precautions